PTPA and cancer: Thus, understanding the molecular mechanism underlying the growth-suppressive effect of PP2A inhibition will not only minimize the unwanted side effect of PP2A inhibition but also facilitate the development of PP2A inhibitors (i.e., cantharidin) as new therapeutic agents for cancer treatment.